AdvaMedDx

2K posts

AdvaMedDx banner
AdvaMedDx

AdvaMedDx

@AdvaMedDx

AdvaMedDx is the national association focused on policy opportunities & challenges facing companies that discover develop & manufacture diagnostic technologies.

Washington, DC Katılım Haziran 2011
436 Takip Edilen1.3K Takipçiler
AdvaMedDx
AdvaMedDx@AdvaMedDx·
Join us for #DxLeadersUnplugged at @_AACC's annual meeting in Anaheim. Engage in a thought-provoking breakfast panel with top diagnostics leaders from AdvaMedDx, AACC, and the California Department of Public Health. Register now: bit.ly/3rAgpBT #AACC
English
0
0
0
145
AdvaMedDx
AdvaMedDx@AdvaMedDx·
Medtech innovators, such as those developing AI/other digital solutions for patients, face a new dynamic for showing product value. Environmental impact is a consideration, too. AdvaMed’s new report helps innovators navigate these changes. advamed.org/member-center/…
English
0
1
0
130
AdvaMedDx
AdvaMedDx@AdvaMedDx·
AdvaMed salutes leadership from @SenatorBurr + @PattyMurray on modernizing FDA review of medical diagnostics tests + technologies. @SenatorBurr raised the issue today, as the HELP Committee works on key FDA improvements to better serve patients.
HELP Committee Dems@HELPCmteDems

Starting shortly: the second HELP Committee hearing on @US_FDA User Fee Agreements. For more information and to watch live, click the link below. help.senate.gov/hearings/fda-u…

English
1
0
0
0
AdvaMedDx
AdvaMedDx@AdvaMedDx·
#Diagnostics stewardship strengthens #antibiotic stewardship programs, which are critical to ensuring appropriate antibiotic use in hospitals #WAAW21 #USAAW21
CDC Antimicrobial Resistance@CDC_AR

Great job! A whopping 91% of U.S. hospitals report having an #antibiotic stewardship program that meets all 7 of CDC’s hospital Core Elements in 2020. Visit the #AntibioticResistance & Patient Safety Portal to view interactive state data maps. bit.ly/3ktQfIA #USAAW21

English
0
0
0
0
AdvaMedDx
AdvaMedDx@AdvaMedDx·
Congrats to our #diagnostics member company, Abbott, for receiving extended EUA for BinaxNOW COVID19 Self Test for asymptomatic, non-prescription, OTC use. #COVID19 testing remains critical for keeping nation safer; another important step in expanding access to OTC testing.
Abbott@AbbottNews

BREAKING: Our BinaxNOW COVID-19 Self Test receives FDA Emergency Use Authorization for asymptomatic, over-the-counter use—no prescription needed. Learn how frequent testing can help restore a sense of normalcy in everyday settings where people gather: abbo.tt/39x0Wq2

English
0
0
1
0
AdvaMedDx
AdvaMedDx@AdvaMedDx·
@davidalim Testing remains critical in our #COVID19 response - AdvaMedDx commends CDC & NIH for launching this initiative!
English
0
0
0
0
David Lim
David Lim@davidalim·
Neat CDC/NIH study called the "Say Yes! COVID Test” initiative is examining if three-time-a-week at-home antigen testing can help cut down on Covid-19 infections. Up to 160,000 people in North Carolina and Tennessee will be given free tests for a month. nih.gov/news-events/ne…
English
1
5
8
0
AdvaMedDx
AdvaMedDx@AdvaMedDx·
The fight against #COVID19 is not over. Remember to get a #diagnostic test that can tell you if you are actively infected with the virus before travelling or visiting friends or family! Let's help each other stay safe. bit.ly/3blcnm0
AdvaMedDx tweet media
English
0
0
1
0
AdvaMedDx
AdvaMedDx@AdvaMedDx·
#MedTech's role in public health remains front and center amid the #COVID response and AdvaMedDx will continue to promote the global value of medtech and #diagnostics through policies that advance greater market access and trade practices. More here: bit.ly/3uvPp3e
AdvaMedDx@AdvaMedDx

How can we enhance patient access to innovative #diagnostic tests and #medtech? AdvaMedDx supports improved coding, coverage, and payment policies to better enable the sector's impact on public health. Learn about the solutions we propose: bit.ly/3uvPp3e

English
0
0
1
0
AdvaMedDx
AdvaMedDx@AdvaMedDx·
How many #COVID19 tests have you received in the past year? We conducted a public survey to find out. Results and insights on #testing are compiled in our new monthly "Dx Data Download" with #data from AdvaMed's COVID-19 Supply Registry.
AdvaMedDx tweet media
English
0
0
0
0
AdvaMedDx
AdvaMedDx@AdvaMedDx·
#Antibioticresistant infections will be the leading cause of death by 2050 if investments in #AMR research don’t increase. #Diagnostic tests, when used appropriately, can save the healthcare system time, money and, most importantly, lives. Learn more: bit.ly/3s4pmPb
AdvaMedDx tweet media
English
0
0
1
0
AdvaMedDx
AdvaMedDx@AdvaMedDx·
AdvaMedDx joined IDSA & 50+ health organizations calling on Congress to increase investments against #AMR. AdvaMedDx members produce diagnostic tools critical to fighting AMR which claims more than 700K lives each year worldwide. bit.ly/3113h84
IDSA@IDSAInfo

W/out greatly increased investments, #antibioticresistant infections will be the leading cause of death by 2050, at a global economic impact of $100 trillion. IDSA & over 50 health organizations call on Congress to increase U.S. investments against #AMR: bit.ly/3ltpUeK

English
0
0
2
0
AdvaMedDx
AdvaMedDx@AdvaMedDx·
The new @POTUS policies on #COVID19 testing and augmented manufacturing capacity of the diagnostics industry, “will improve our collective efforts to recover and rebound from the pandemic”, said Susan Van Meter of AdvaMedDx. Read more: bit.ly/3loOa1I
English
0
0
0
0

Keşfet

@_aacc @SenatorBurr @PattyMurray @CDCgov @NIH @davidalim @elonmusk @BarackObama